The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2019
Filed:
Mar. 15, 2013
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Mark D. Gustavson, Greensboro, NC (US);
Jason Christiansen, Carlsbad, CA (US);
Assignee:
Novartis AG, Basel, CH;
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/68 (2006.01); G01N 33/574 (2006.01); G01N 33/74 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); G01N 33/574 (2013.01); G01N 33/57415 (2013.01); G01N 33/57484 (2013.01); G01N 33/74 (2013.01); G01N 33/743 (2013.01); G01N 2800/50 (2013.01); G01N 2800/54 (2013.01);
Abstract
The present technology relates generally to determining a risk of recurrence of disease in a cancer patient. In particular, this approach to determining a risk of recurrence involves utilizing standardized quantitative assessments of the level of biomarker expression selected from estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki-67 (Ki67) in a patient's tumor to determine the risk of recurrence, thereby allowing a caretaker to determine the best course of treatment for the patient.